Related references
Note: Only part of the references are listed.Purification of influenza virus-like particles using sulfated cellulose membrane adsorbers
Sofia B. Carvalho et al.
JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY (2018)
Microbioreactor Systems for Accelerated Bioprocess Development
Johannes Hemmerich et al.
BIOTECHNOLOGY JOURNAL (2018)
Structural-based designed modular capsomere comprising HA1 for low-cost poultry influenza vaccination
Jarurin Waneesorn et al.
VACCINE (2018)
Microbioreactor Systems for Accelerated Bioprocess Development
Johannes Hemmerich et al.
BIOTECHNOLOGY JOURNAL (2018)
Integrated molecular and bioprocess engineering for bacterially produced immunogenic modular virus-like particle vaccine displaying 18kDa rotavirus antigen
Alemu Tekewe et al.
BIOTECHNOLOGY AND BIOENGINEERING (2017)
A Systems Vaccinology Approach Reveals Temporal Transcriptomic Changes of Immune Responses to the Yellow Fever 17D Vaccine
Jue Hou et al.
JOURNAL OF IMMUNOLOGY (2017)
Systems analysis of protective immune responses to RTS, S malaria vaccination in humans
Dmitri Kazmin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
The complexity and cost of vaccine manufacturing - An overview
Stanley Plotkin et al.
VACCINE (2017)
Platform technologies for modern vaccine manufacturing
Hayley K. Charlton Hume et al.
VACCINE (2017)
Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens
Peter Pushko et al.
VIROLOGY (2017)
Middle East respiratory syndrome coronavirus vaccines: current status and novel approaches
Nisreen M. A. Okba et al.
CURRENT OPINION IN VIROLOGY (2017)
Universal label-free in-process quantification of influenza virus-like particles
Sofia B. Carvalho et al.
BIOTECHNOLOGY JOURNAL (2017)
A DNA inducing VLP vaccine designed for HIV and tested in mice
Alexandre Calazans et al.
PLOS ONE (2017)
Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
Katharine A. Collins et al.
SCIENTIFIC REPORTS (2017)
Integration of Novel Materials and Advanced Genomic Technologies into New Vaccine Design
Wenzhen Liao et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
Immunological Principles Guiding the Rational Design of Particles for Vaccine Delivery
Katelyn T. Gause et al.
ACS NANO (2017)
Characterization of Non-Infectious Virus-Like Particle Surrogates for Viral Clearance Applications
Sarah Johnson et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2017)
Systems immunology: just getting started
Mark M. Davis et al.
NATURE IMMUNOLOGY (2017)
Virus-like particles as drug delivery vectors
Michal Zdanowicz et al.
ACTA BIOCHIMICA POLONICA (2016)
Bioorthogonal Strategy for Bioprocessing of Specific-Site-Functionalized Enveloped Influenza-Virus-Like Particles
Sofia B. Carvalho et al.
BIOCONJUGATE CHEMISTRY (2016)
The global threat of Zika virus to pregnancy: epidemiology, clinical perspectives, mechanisms, and impact
Phillipe Boeuf et al.
BMC MEDICINE (2016)
Purification of HIV-1 gag virus-like particles and separation of other extracellular particles
Petra Steppert et al.
JOURNAL OF CHROMATOGRAPHY A (2016)
Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design
Rino Rappuoli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses
Donald M. Carter et al.
JOURNAL OF VIROLOGY (2016)
Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses
Christoph M. Janitzek et al.
MALARIA JOURNAL (2016)
New approaches and omics tools for mining of vaccine candidates against vector-borne diseases
Josipa Kules et al.
MOLECULAR BIOSYSTEMS (2016)
High-throughput characterization of virus-like particles by interlaced size-exclusion chromatography
Christopher Ladd Effio et al.
VACCINE (2016)
Preparation of quadri-subtype influenza virus-like particles using bovine immunodeficiency virus gag protein
Irina Tretyakova et al.
VIROLOGY (2016)
Biochemical and proteomic characterization of retrovirus Gag based microparticles carrying melanoma antigens
Reet Kurg et al.
SCIENTIFIC REPORTS (2016)
A Modular Vaccine Development Platform Based on Sortase-Mediated Site-Specific Tagging of Antigens onto Virus-Like Particles
Shubing Tang et al.
SCIENTIFIC REPORTS (2016)
Bacterial superglue enables easy development of efficient virus-like particle based vaccines
Susan Thrane et al.
JOURNAL OF NANOBIOTECHNOLOGY (2016)
Expression and Purification of Virus-like Particles for Vaccination
Maria T. Arevalo et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2016)
Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization
Karl D. Brune et al.
SCIENTIFIC REPORTS (2016)
Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection
Chongbo Zhao et al.
VACCINES (2016)
A rapid and simple screening method to identify conditions for enhanced stability of modular vaccine candidates
Alemu Tekewe et al.
BIOCHEMICAL ENGINEERING JOURNAL (2015)
Emerging influenza viruses and the prospect of a universal influenza virus vaccine
Florian Krammer
BIOTECHNOLOGY JOURNAL (2015)
Enhanced production of porcine circovirus type 2 (PCV2) virus-like particles in Sf9 cells by translational enhancers
Yangkun Liu et al.
BIOTECHNOLOGY LETTERS (2015)
Enveloped virus-like particle platforms: vaccines of the future?
Fabien Pitoiset et al.
EXPERT REVIEW OF VACCINES (2015)
Single-use in the biopharmaceutical industry: A review of current technology impact, challenges and limitations
Adriana G. Lopes
FOOD AND BIOPRODUCTS PROCESSING (2015)
Protein Crystallography in Vaccine Research and Development
Enrico Malito et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
An overview of bioinformatics tools for epitope prediction: Implications on vaccine development
Ruth E. Soria-Guerra et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2015)
Downstream processing of virus-like particles: Single-stage and multi-stage aqueous two-phase extraction
Christopher Ladd Effio et al.
JOURNAL OF CHROMATOGRAPHY A (2015)
White Paper on Continuous Bioprocessing May 20-21, 2014 Continuous Manufacturing Symposium
Konstantin B. Konstantinov et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells
Ki-Hye Kim et al.
JOURNAL OF VIROLOGY (2015)
Establishing a Global Vaccine-Development Fund
Stanley A. Plotkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Whole-Chain Tick Saliva Proteins Presented on Hepatitis B Virus Capsid-Like Particles Induce High-Titered Antibodies with Neutralizing Potential
Philipp Kolb et al.
PLOS ONE (2015)
A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA
Susan Thrane et al.
PLOS ONE (2015)
Synthetic biology design to display an 18 kDa rotavirus large antigen on a modular virus-like particle
Linda H. L. Lua et al.
VACCINE (2015)
Recent advances in recombinant protein-based malaria vaccines
Simon J. Draper et al.
VACCINE (2015)
Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets
Ye V. Liu et al.
VACCINE (2015)
An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus
Louis M. Schwartzman et al.
MBIO (2015)
Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platform
John P. O'Rourke et al.
CURRENT OPINION IN VIROLOGY (2015)
Emerging influenza viruses and the prospect of a universal influenza virus vaccine
Florian Krammer
BIOTECHNOLOGY JOURNAL (2015)
Structural and Computational Biology in the Design of Immunogenic Vaccine Antigens
Lassi Liljeroos et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
The immune epitope database (IEDB) 3.0
Randi Vita et al.
NUCLEIC ACIDS RESEARCH (2015)
Tandem Fusion of Hepatitis B Core Antigen Allows Assembly of Virus-Like Particles in Bacteria and Plants with Enhanced Capacity to Accommodate Foreign Proteins
Hadrien Peyret et al.
PLOS ONE (2015)
Improved Production Efficiency of Virus-Like Particles by the Baculovirus Expression Vector System
Javier Lopez-Vidal et al.
PLOS ONE (2015)
Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head
Lidewij C. M. Wiersma et al.
VACCINES (2015)
Immunogenic Subviral Particles Displaying Domain III of Dengue 2 Envelope Protein Vectored by Measles Virus
Indira S. Harahap-Carrillo et al.
VACCINES (2015)
The economics of virus-like particle and capsomere vaccines
Yap P. Chuan et al.
BIOCHEMICAL ENGINEERING JOURNAL (2014)
Bioengineering Virus-Like Particles as Vaccines
Linda H. L. Lua et al.
BIOTECHNOLOGY AND BIOENGINEERING (2014)
Enveloped Virus-Like Particle Expression of Human Cytomegalovirus Glycoprotein B Antigen Induces Antibodies with Potent and Broad Neutralizing Activity
Marc Kirchmeier et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Pathogen-like particles: biomimetic vaccine carriers engineered at the nanoscale
Joseph A. Rosenthal et al.
CURRENT OPINION IN BIOTECHNOLOGY (2014)
Deletion modification enhances anthrax specific immunity and protective efficacy of a hepatitis B core particle-based anthrax epitope vaccine
Ying Yin et al.
IMMUNOBIOLOGY (2014)
Immune activation alters cellular and humoral responses to yellow fever 17D vaccine
Enoch Muyanja et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Chimeric Virus-Like Particle Vaccines Displaying Conserved Enterovirus 71 Epitopes Elicit Protective Neutralizing Antibodies in Mice through Divergent Mechanisms
Xiaohua Ye et al.
JOURNAL OF VIROLOGY (2014)
Hyperglycosylated Stable Core Immunogens Designed To Present the CD4 Binding Site Are Preferentially Recognized by Broadly Neutralizing Antibodies
Jidnyasa Ingale et al.
JOURNAL OF VIROLOGY (2014)
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface
Jinghe Huang et al.
NATURE (2014)
Pandemic Preparedness and Response - Lessons from the H1N1 Influenza of 2009
Harvey V. Fineberg
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Significant Productivity Improvement of the Baculovirus Expression Vector System by Engineering a Novel Expression Cassette
Silvia Gomez-Sebastian et al.
PLOS ONE (2014)
Chimaeric Virus-Like Particles Derived from Consensus Genome Sequences of Human Rotavirus Strains Co-Circulating in Africa
Khuzwayo C. Jere et al.
PLOS ONE (2014)
Protective efficacy of a bacterially produced modular capsomere presenting M2e from influenza: Extending the potential of broadly cross-protecting epitopes
Nani Wibowo et al.
VACCINE (2014)
Advances in Miniaturized Instruments for Genomics
Cihun-Siyong Alex Gong et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Preclinical efficacy and safety of an anti-IL-1 beta vaccine for the treatment of type 2 diabetes
Gunther Spohn et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2014)
Modular engineering of a microbially-produced viral capsomere vaccine for influenza
Nani Wibowo et al.
CHEMICAL ENGINEERING SCIENCE (2013)
Reengineering viruses and virus-like particles through chemical functionalization strategies
Mark Thomas Smith et al.
CURRENT OPINION IN BIOTECHNOLOGY (2013)
Nipah Virus Envelope-Pseudotyped Lentiviruses Efficiently Target ephrinB2-Positive Stem Cell Populations In Vitro and Bypass the Liver Sink When Administered In Vivo
Karina Palomares et al.
JOURNAL OF VIROLOGY (2013)
Isolation of human monoclonal antibodies from peripheral blood B cells
Jinghe Huang et al.
NATURE PROTOCOLS (2013)
Bacterially Produced Recombinant Influenza Vaccines Based on Virus-Like Particles
Andrea Jegerlehner et al.
PLOS ONE (2013)
Single-use disposable technologies for biopharmaceutical manufacturing
Abhinav A. Shukla et al.
TRENDS IN BIOTECHNOLOGY (2013)
Sensitivity of immune response quality to influenza helix 190 antigen structure displayed on a modular virus-like particle
Melisa R. Anggraeni et al.
VACCINE (2013)
Bovine papillomavirus-like particles presenting conserved epitopes from membrane-proximal external region of HIV-1 gp41 induced mucosal and systemic antibodies
Yougang Zhai et al.
VACCINE (2013)
Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice
Upasana Arora et al.
VACCINE (2013)
Intranasal vaccination with H5, H7 and H9 hemagglutinins co-localized in a virus-like particle protects ferrets from multiple avian influenza viruses
Irina Tretyakova et al.
VIROLOGY (2013)
A novel platform for virus-like particle-display of flaviviral envelope domain III: induction of Dengue and West Nile virus neutralizing antibodies
Anthony J. S. Chua et al.
VIROLOGY JOURNAL (2013)
T-cell epitope vaccine design by immunoinformatics
Atanas Patronov et al.
OPEN BIOLOGY (2013)
A monolith purification process for virus-like particles from yeast homogenate
Claire S. Burden et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2012)
A Virus-Like Particle That Elicits Cross-Reactive Antibodies to the Conserved Stem of Influenza Virus Hemagglutinin
Anette Schneemann et al.
JOURNAL OF VIROLOGY (2012)
Toolbox for Non-Intrusive Structural and Functional Analysis of Recombinant VLP Based Vaccines: A Case Study with Hepatitis B Vaccine
Anke M. Mulder et al.
PLOS ONE (2012)
Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development
Natasha Kushnir et al.
VACCINE (2012)
Pandemic H1N1 influenza virus-like particles are immunogenic and provide protective immunity to pigs
Hyun-Mi Pyo et al.
VACCINE (2012)
Virus like particle based strategy to elicit HIV-protective antibodies to the alpha-helic regions of gp41
C. Pastori et al.
VIROLOGY (2012)
On the Effect of Thermodynamic Equilibrium on the Assembly Efficiency of Complex Multi-Layered Virus-Like Particles (VLP): the Case of Rotavirus VLP
Antonio Roldao et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
Upasana Arora et al.
JOURNAL OF NANOBIOTECHNOLOGY (2012)
Surface Functionalization of Virus-Like Particles by Direct Conjugation Using Azide-Alkyne Click Chemistry
Kedar G. Patel et al.
BIOCONJUGATE CHEMISTRY (2011)
Progress towards a universal influenza vaccine
Tamar Ben-Yedidia
FUTURE VIROLOGY (2011)
Large-scale production and purification of VLP-based vaccines
Tiago Vicente et al.
JOURNAL OF INVERTEBRATE PATHOLOGY (2011)
The Second-Generation Active Aβ Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects
Christoph Wiessner et al.
JOURNAL OF NEUROSCIENCE (2011)
Designing the Next Generation of Vaccines for Global Public Health
Fabio Bagnoli et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2011)
Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity
Jae-Min Song et al.
PLOS ONE (2011)
Murine Polyomavirus Virus-Like Particles Carrying Full-Length Human PSA Protect BALB/c Mice from Outgrowth of a PSA Expressing Tumor
Mathilda Eriksson et al.
PLOS ONE (2011)
Protein delivery using engineered virus-like particles
Stanislaw J. Kaczmarczyk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Virus engineering: functionalization and stabilization
Mauricio G. Mateu
PROTEIN ENGINEERING DESIGN & SELECTION (2011)
Synthetic Biology Moving into the Clinic
Warren C. Ruder et al.
SCIENCE (2011)
High-throughput process development for biopharmaceutical drug substances
Rahul Bhambure et al.
TRENDS IN BIOTECHNOLOGY (2011)
A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines
Anton P. J. Middelberg et al.
VACCINE (2011)
Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes
Peter Pushko et al.
VACCINE (2011)
SplitCore: An exceptionally versatile viral nanoparticle for native whole protein display regardless of 3D structure
Andreas Walker et al.
SCIENTIFIC REPORTS (2011)
EPSVR and EPMeta: prediction of antigenic epitopes using support vector regression and multiple server results
Shide Liang et al.
BMC BIOINFORMATICS (2010)
Virus-like particles in vaccine development
Antonio Roldao et al.
EXPERT REVIEW OF VACCINES (2010)
Reverse Vaccinology: Developing Vaccines in the Era of Genomics
Alessandro Sette et al.
IMMUNITY (2010)
Virus assembly occurs following a pH- or Ca2+-triggered switch in the thermodynamic attraction between structural protein capsomeres
Yap P. Chuan et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2010)
Cucumber mosaic virus as the expression system for a potential vaccine against Alzheimer's disease
A. Vitti et al.
JOURNAL OF VIROLOGICAL METHODS (2010)
Neutralizing Epitopes of Influenza Virus Hemagglutinin: Target for the Development of a Universal Vaccine against H5N1 Lineages
Mookkan Prabakaran et al.
JOURNAL OF VIROLOGY (2010)
AntigenDB: an immunoinformatics database of pathogen antigens
Hifzur Rahman Ansari et al.
NUCLEIC ACIDS RESEARCH (2010)
Versatile Virus-Like Particle Carrier for Epitope Based Vaccines
Alain C. Tissot et al.
PLOS ONE (2010)
A replication-incompetent Rift Valley fever vaccine: Chimeric virus-like particles protect mice and rats against lethal challenge
Robert B. Mandell et al.
VIROLOGY (2010)
被撤回的出版物: A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice (Retracted article. See vol. 232, pg. 266, 2016)
Gunther Spohn et al.
VIROLOGY JOURNAL (2010)
Challenges for the production of virus-like particles in insect cells: The case of rotavirus-like particles
Laura A. Palomares et al.
BIOCHEMICAL ENGINEERING JOURNAL (2009)
The use of genomics in microbial vaccine development
Stefania Bambini et al.
DRUG DISCOVERY TODAY (2009)
Analysis of Modified Human Papillomavirus Type 16 L1 Capsomeres: the Ability To Assemble into Larger Particles Correlates with Higher Immunogenicity
Lysann Schaedlich et al.
JOURNAL OF VIROLOGY (2009)
COBEpro: a novel system for predicting continuous B-cell epitopes
Michael J. Sweredoski et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2009)
Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys
Tong-Ming Fu et al.
VACCINE (2009)
Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge
Joel R. Haynes et al.
VACCINE (2009)
Induction of mucosal and systemic antibody responses against the HIV coreceptor CCR5 upon intramuscular immunization and aerosol delivery of a virus-like particle based vaccine
Zoe Hunter et al.
VACCINE (2009)
Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeres
Yoshihiko Murata et al.
VIROLOGY JOURNAL (2009)
The Role of Genomics in Tracking the Evolution of Influenza A Virus
Alice Carolyn McHardy et al.
PLOS PATHOGENS (2009)
Immunodrugs: Therapeutic VLP-Based Vaccines for Chronic Diseases
Gary T. Jennings et al.
Annual Review of Pharmacology and Toxicology (2008)
Escherichia coli-based cell-free synthesis of virus-like particles
Bradley C. Bundy et al.
BIOTECHNOLOGY AND BIOENGINEERING (2008)
Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design
Juliana Bessa et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Plant-produced hepatitis B core protein chimera carrying anthrax protective antigen domain-4
Katarzyna Bandurska et al.
HYBRIDOMA (2008)
Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: New particulate Lyme disease vaccines
Michael Nassal et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2008)
Predicting linear B-cell epitopes using string kernels
Yasser El-Manzalawy et al.
JOURNAL OF MOLECULAR RECOGNITION (2008)
Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure:: a double-blind, randomised, placebo-controlled phase IIa study
Alain C. Tissot et al.
LANCET (2008)
PVS: a web server for protein sequence variability analysis tuned to facilitate conserved epitope discovery
Maria Garcia-Boronat et al.
NUCLEIC ACIDS RESEARCH (2008)
Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies
Marina De Filette et al.
VACCINE (2008)
Versatile RHDV virus-like particles: Incorporation of antigens by genetic modification and chemical conjugation
Matthew Peacey et al.
BIOTECHNOLOGY AND BIOENGINEERING (2007)
A viral nanoparticle with dual function as an anthrax antitoxin and vaccine
Darly J. Manayani et al.
PLOS PATHOGENS (2007)
Virus-like particles-flexible platforms for vaccine development
Bryce Chackerian
EXPERT REVIEW OF VACCINES (2007)
Cucumber mosaic virus as a presentation system for a double hepatitis C virus-derived epitope
M. Nuzzaci et al.
ARCHIVES OF VIROLOGY (2007)
A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11
Katharina Slupetzky et al.
VACCINE (2007)
Predicting class II MHC-peptide binding: A kernel based approach using similarity scores
Jesper Salomon et al.
BMC BIOINFORMATICS (2006)
Vaccine manufacturing: challenges and solutions
Jeffrey B. Ulmer et al.
NATURE BIOTECHNOLOGY (2006)
Rotavirus-like particles primary recovery from insect cells in aqueous two-phase systems
Jorge Benavides et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2006)
Virus-like particles: Passport to immune recognition
Elizabeth V. L. Grgacic et al.
METHODS (2006)
Protection of rabbits against cutaneous papillomavirus infection using recombinant tobacco mosaic virus containing L2 capsid epitopes
Kenneth E. Palmer et al.
VACCINE (2006)
Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults
Thomas M. Kuendig et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV)
Marija Mihailova et al.
VACCINE (2006)
Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system
YD Chen et al.
MOLECULAR IMMUNOLOGY (2006)
Towards the preparative and large-scale precision manufacture of virus-like particles
LK Pattenden et al.
TRENDS IN BIOTECHNOLOGY (2005)
Use of rotavirus virus-like particles as surrogates to evaluate virus persistence in shellfish
F Loisy et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2005)
Altering the tropism of lentiviral vectors through pseudotyping
J Cronin et al.
CURRENT GENE THERAPY (2005)
A single vaccination with polyomavirus VP1/VP2Her2 virus-like particles prevents outgrowth of HER-2/neu-expressing tumors
K Tegerstedt et al.
CANCER RESEARCH (2005)
Frontline:: A therapeutic vaccine for nicotine dependence:: preclinical efficacy, and phase I safety and immunogenicity
P Maurer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Why are pharmaceutical companies gradually abandoning vaccines?
PA Offit
HEALTH AFFAIRS (2005)
Development of a candidate vaccine for Newcastle disease virus by epitope display in the Cucumber mosaic virus capsid protein
Y Zhao et al.
BIOTECHNOLOGY LETTERS (2005)
A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula
M Nassal et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
DNA vaccine-encapsulated virus-like particles derived from an orally transmissible virus stimulate mucosal and systemic immune responses by oral administration
S Takamura et al.
GENE THERAPY (2004)
Overcoming antigen masking of anti-amyloidbeta antibodies reveals breaking of B cell tolerance by virus-like particles in amyloidbeta immunized amyloid precursor protein transgenic mice
QY Li et al.
BMC NEUROSCIENCE (2004)
Expression of foot-and-mouth disease virus epitopes in tobacco by a tobacco mosaic virus-based vector
LG Wu et al.
VACCINE (2003)
A malaria vaccine candidate based on a hepatitis B virus core platform
M Sällberg et al.
INTERVIROLOGY (2002)
Route of administration of chimeric BPV1VLP determines the character of the induced immune responses
XS Liu et al.
IMMUNOLOGY AND CELL BIOLOGY (2002)
Chimeric papillomavirus-like particles expressing a foreign epitope on capsid surface loops
K Slupetzky et al.
JOURNAL OF GENERAL VIROLOGY (2001)
Inactivated recombinant plant virus protects dogs from a lethal challenge with canine parvovirus
JPM Langeveld et al.
VACCINE (2001)
Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat
A Rennermalm et al.
VACCINE (2001)
Immunization with a chimeric tobacco mosaic virus containing an epitope of outer membrane protein F of Pseudomonas aeruginosa provides protection against challenge with P-aeruginosa
J Staczek et al.
VACCINE (2000)